Your browser doesn't support javascript.
loading
Treatment of immunocompromised COVID-19 patients with convalescent plasma.
Fung, Monica; Nambiar, Ashok; Pandey, Suchi; Aldrich, J Matthew; Teraoka, Justin; Freise, Christopher; Roberts, John; Chandran, Sindhu; Hays, Steven R; Bainbridge, Emma; DeVoe, Catherine; Roque Gardner, Annelys; Yokoe, Deborah; Henrich, Timothy J; Babik, Jennifer M; Chin-Hong, Peter.
Afiliação
  • Fung M; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Nambiar A; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Pandey S; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Aldrich JM; Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, C,, USA.
  • Teraoka J; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Freise C; Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Roberts J; Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Chandran S; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Hays SR; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Bainbridge E; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • DeVoe C; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Roque Gardner A; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Yokoe D; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Henrich TJ; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Babik JM; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Chin-Hong P; Division of Infectious Disease, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Transpl Infect Dis ; 23(2): e13477, 2021 Apr.
Article em En | MEDLINE | ID: mdl-32989856

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Hospedeiro Imunocomprometido / COVID-19 / Rejeição de Enxerto / Imunossupressores Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Hospedeiro Imunocomprometido / COVID-19 / Rejeição de Enxerto / Imunossupressores Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article